Haleon (NYSE:HLN) Stock Rating Reaffirmed by Argus : vimarsa

Haleon (NYSE:HLN – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at Argus in a report issued on Tuesday, Benzinga reports. They currently have a $10.00 price target on the stock. Argus’ price target would indicate a potential upside of 18.76% from the company’s previous close. Haleon Stock Down 0.1 % […]

Related Keywords

United States , Washington , America , Asia Pacific , Washington Trust Advisors Inc , Corefirst Bank , Haleon Company Profile , Resurgent Financial Advisors , Barclays Plc , Get Free Report , Stock Down , Finance Advisors , Trust Advisors , First Bank , North America , Middle East , Latin America , Haleon Daily , Haleon , Nyse Hln , Hln , Medical , Reiterated Rating , Argus ,